JLE

Hépato-Gastro & Oncologie Digestive

MENU

La présence du variant Pi*Z de l’α1-antitrypsine augmente le risque de cirrhose alcoolique et de cirrhose « métabolique » Volume 26, numéro 5, Mai 2019

  • [1] Ferrarotti I., Ottaviani S., De Silvestri A., Corsico A.G. Update on α-antitrypsin deficiency. Breathe. 2018;14:e17-e24. 1
  • [2] Lomas DA, Hurst JR, Gooptu B. Update on α1-antitrypsin deficiency: New therapies. J Hepatol 2016 ; 65 : 413-24.
  • [3] Patel D., Teckman J.H. Alpha-1-antitrypsin deficiency liver disease. Clin Liver Dis. 2018;22:643-655.
  • [4] Morin T., Martin J.P., Feldmann G., Rueff B., Benhamou J.P., Ropartz C. Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association. Lancet. 1975;i:250-251.
  • [5] Romeo S., Kozlitina J., Xing C. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461-1465.
  • [6] Salameh H., Raff E., Erwin A. PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease. Am J Gastroenterol. 2015;110:846-856.
  • [7] Stickel F., Buch S., Lau K. Genetic variation in the gene is associated with alcoholic liver injury in caucasians. Hepatology. 2011;53:86-95. PNPLA3
  • [8] Meroni M, Longo M, Rametta R, Dongiovanni P. Genetic and epigenetic modifiers of alcoholic liver disease. Int J Mol Sci 2018 ; 19 : 3857-78.